Assessing Whether Myriad Genetics, Inc (NASDAQ: MYGN) Is Over- Or Undervalued
Myriad Genetics, Inc (MYGN) concluded trading on Thursday at a closing price of $14.50, with 2.68 million shares of worth about $38.92 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -37.74% during that period and on December 12, 2024 the price saw a […]
